Skip to main content
Clinical Trials/NCT03770169
NCT03770169
Completed
Not Applicable

Validation of Patient Reported Outcome Measures for Use in Vulvodynia

Ipsen4 sites in 1 country20 target enrollmentFebruary 18, 2019
ConditionsVulvodynia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vulvodynia
Sponsor
Ipsen
Enrollment
20
Locations
4
Primary Endpoint
Validation of mVPAQ
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The overall aim of this project is to demonstrate content validity and usability of the modified Vulvar Pain Assessment Questionnaire (mVPAQ), the modified Female Sexual Function Index (mFSFI), and pain on intercourse Numeric Rating Scale (NRS) for adult patients with Vulvodynia

Registry
clinicaltrials.gov
Start Date
February 18, 2019
End Date
September 19, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Ipsen
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Fluent in understanding, speaking and reading US-English
  • Have vulvodynia with pain for at least 6 months

Exclusion Criteria

  • Clinically significant history of alcohol/drug abuse or dependence within the last 2 years

Outcomes

Primary Outcomes

Validation of mVPAQ

Time Frame: 1 week

Cognitive debrief and usability through interviews and completion of an electronic diary

Validation of mFSFI

Time Frame: 1 week

Cognitive debrief and usability through interviews and completion of an electronic diary

Validation of Pain on Intercourse Numeric Rating Scale (NRS)

Time Frame: 1 week

Cognitive debrief and usability through interviews and completion of an electronic diary. Pain on Intercourse NRS that describes pain experienced during this sexual intercourse episode by number. The higher is the number the worse is pain.

Secondary Outcomes

  • Vulvar pain NRS(1 week)

Study Sites (4)

Loading locations...

Similar Trials